Stock Price
4.17
Daily Change
0.04 0.97%
Monthly
16.16%
Yearly
136.93%
Q2 Forecast
4.07

EDAP TMS reported EUR31.4M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
AngioDynamics USD 71.96M 3.68M Sep/2025
Boston Scientific USD 4.57B 868M Mar/2026
EDAP TMS EUR 31.4M 2.71M Sep/2025
Henry Schein USD 3.3B 69M Mar/2026
Medtronic USD 9.5B 440M Dec/2025
Plus Therapeutics USD 7.96M 4.36M Mar/2026
Veracyte USD 56.11M 3.82M Mar/2026